White label – Pompe disease - ClinicalTrials.eu

Study on Additional Chemotherapy with Osimertinib, Carboplatin, and Cisplatin for Patients with Advanced Non-Small Cell Lung Cancer and EGFR Mutation

Not recruiting

2 1 1 1
Investigated Diseases:
- Non-small cell lung cancer
Investigated Drugs:
Study on the Effects of Mebufotenin (GH001) for Patients with Treatment-Resistant Depression

Not recruiting

2 1
Investigated Diseases:
- Major depression
Investigated Drugs:
- Mebufotenin
Study Comparing Docetaxel Alone and Docetaxel with Radium-223 for Patients with Metastatic Castration-Resistant Prostate Cancer

Not recruiting

3 1 1 1
Investigated Diseases:
- Hormone-refractory prostate cancer
Investigated Drugs:
- Radium Ra 223 Dichloride
Study on the Effectiveness of Bevacizumab and Ranibizumab in Treating Age-Related Macular Degeneration in Patients with Genetic Variations

Not recruiting

3 1 1 1
Investigated Diseases:
- Age-related macular degeneration
Investigated Drugs:
- Ranibizumab
- Bevacizumab
Study on Ixekizumab for Preserving Insulin Production in Newly Diagnosed Type 1 Diabetes Patients

Not recruiting

2 1 1
Investigated Diseases:
- Type 1 diabetes mellitus
Investigated Drugs:
- Ixekizumab
Study on the Effectiveness of Bortezomib, Melphalan, and Prednisone vs. Carfilzomib, Lenalidomide, and Dexamethasone in Older Adults with Newly Diagnosed Multiple Myeloma

Not recruiting

3 1 1 1
Investigated Drugs:
Study on High-Intensity Focused Ultrasound and Leuprorelin Acetate for Intermediate Risk Prostate Cancer Patients

Not recruiting

2 1 1 1
Investigated Drugs:
- Leuprorelin Acetate
Study of Pembrolizumab and Azacitidine for Patients with Acute Myeloid Leukemia Facing Imminent Relapse

Not recruiting

2 1 1 1
Investigated Diseases:
- Acute myeloid leukaemia
Investigated Drugs:
- Azacitidine
- Pembrolizumab
Study of Selinexor for Patients with Previously Treated Myelofibrosis

Not recruiting

2 1 1 1
Investigated Diseases:
- Primary myelofibrosis
- Myelofibrosis
Investigated Drugs:
- Selinexor
Study of Sasanlimab and Sacituzumab Govitecan for Patients with BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

Not recruiting

2 1 1 1
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies